Literature DB >> 20595273

Effect of psoriatic arthritis according to the affected categories of the international classification of functioning, disability and health.

William J Taylor1, Philip J Mease, Adewale Adebajo, Peter J Nash, Marie Feletar, Dafna D Gladman.   

Abstract

OBJECTIVE: To determine the categories of the International Classification of Functioning, Disability and Health (ICF) checklist and core sets of rheumatoid arthritis and ankylosing spondylitis frequently occurring in people with psoriatic arthritis (PsA) and to compare the number of such categories with scores on self-report measures of participation restrictions and activity limitations.
METHODS: Data were collected from 94 patients with PsA attending rheumatology clinics in 6 centers. For each ICF category affected by PsA in at least 30% of patients, the percentage of such patients was determined for Body Structures, Body Functions, Activities and Participation, and Environmental Factors. A count of all affected categories by ICF chapter was compared to patient self-report scores on a number of functional and health status instruments using Spearman's correlation.
RESULTS: There were 25 categories in the Body Functions section, 6 categories in the Body Structures section, and 51 categories in the Activities and Participation section that were relevant in at least 30% of participants. Thirteen Environmental Factors were facilitating and 1 Environmental Factor (climate) was a barrier in at least 30% of participants. The number of involved Activities and Participation categories by chapter did not correlate in predictable ways with self-report measures of participation restrictions and activity limitations.
CONCLUSION: PsA is associated with a wide range of impairments, limitations, and restrictions across the ICF categories. People with PsA find environmental factors to be helpful more often than to be barriers. The unexpected pattern of correlation between ICF chapters and self-report measures suggests the need for a better way of quantitatively representing the ICF concepts.

Entities:  

Mesh:

Year:  2010        PMID: 20595273     DOI: 10.3899/jrheum.091315

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Impact of psoriatic arthritis on the patient: through the lens of the WHO International Classification of Functioning, Health, and Disability.

Authors:  William J Taylor
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

Review 2.  Patient-Reported Outcomes in Psoriatic Arthritis.

Authors:  Ana-Maria Orbai; Alexis Ogdie
Journal:  Rheum Dis Clin North Am       Date:  2016-03-16       Impact factor: 2.670

3.  Linking the patient experience of foot involvement related to psoriatic arthritis to the International Classification of Functioning, Disability and Health.

Authors:  Kate Carter; Caterina Tannous; Steven Walmsley; Keith Rome; Deborah E Turner
Journal:  Rheumatol Adv Pract       Date:  2020-07-11

4.  Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.

Authors:  Ana-Maria Orbai; Philip J Mease; Maarten de Wit; Umut Kalyoncu; Willemina Campbell; William Tillett; Lihi Eder; Musaab Elmamoun; Oliver FitzGerald; Dafna D Gladman; Niti Goel; Laure Gossec; Chris A Lindsay; Ingrid Steinkoenig; Philip S Helliwell; Neil J McHugh; Vibeke Strand; Alexis Ogdie
Journal:  J Rheumatol       Date:  2016-05       Impact factor: 4.666

5.  Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.

Authors:  Josef S Smolen; Jürgen Braun; Maxime Dougados; Paul Emery; Oliver Fitzgerald; Philip Helliwell; Arthur Kavanaugh; Tore K Kvien; Robert Landewé; Thomas Luger; Philip Mease; Ignazio Olivieri; John Reveille; Christopher Ritchlin; Martin Rudwaleit; Monika Schoels; Joachim Sieper; Martinus de Wit; Xenofon Baraliakos; Neil Betteridge; Ruben Burgos-Vargas; Eduardo Collantes-Estevez; Atul Deodhar; Dirk Elewaut; Laure Gossec; Merryn Jongkees; Mara Maccarone; Kurt Redlich; Filip van den Bosch; James Cheng-Chung Wei; Kevin Winthrop; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2013-06-08       Impact factor: 19.103

6.  Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set.

Authors:  Umut Kalyoncu; Alexis Ogdie; Willemina Campbell; Clifton O Bingham; Maarten de Wit; Dafna D Gladman; Philip Mease; Ingrid Steinkoenig; Vibeke Strand; Victoria G Riese; Ana-Maria Orbai
Journal:  RMD Open       Date:  2016-03-03

7.  Cost-effectiveness analysis of secukinumab versus other biologics and apremilast in the treatment of active Psoriatic arthritis: a Finnish perspective.

Authors:  Timo Purmonen; Kari Puolakka; Devarshi Bhattacharyya; Minal Jain; Janne Martikainen
Journal:  Cost Eff Resour Alloc       Date:  2018-11-16

8.  Development of a national survey on foot involvement among people with psoriatic arthritis in Australia using a best practice approach: a survey development protocol.

Authors:  Kate Carter; Steven Walmsley; Keith Rome; Deborah E Turner
Journal:  J Foot Ankle Res       Date:  2020-08-26       Impact factor: 2.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.